Scientists

Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.

SNMMI 2018 Future Leaders Academy

The SNMMI Future Leaders Academy is the most recent addition to the SNMMI leadership development strategy. The SNMMI Future Leaders Academy training focuses on setting a clear plan for increasing leadership abilities by developing the necessary skills and organizational expertise to enhance performance and ultimately evolve into a leader both within the nuclear medicine and molecular imaging community and the society.

The academy will also help you to gain knowledge in fundamental leadership techniques from professionally recognized leadership groups and current SNMMI leaders.

Learn more about the Future Leaders Academy HERE.  

The Future Leaders Academy will be held January 25-28, 2018 in conjunction with the SNMMI Mid-Winter Meeting in Orlando, FL. By submitting an application you are affirming your availability on these dates and your willingness to attend the academy. If accepted, it is preferred that you make arrangements to stay for the entire Mid-Winter Meeting.  

All applications must be received by September 1, 2017, 5:00 pm (ET) 

Coding and Reimbursement

The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.

For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.

For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.

Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!

Dose Optimization

In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.

SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.

 

Guidelines

The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.

View Guidelines.

Focusing on the Future of Molecular Imaging

SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.

Access resources.

The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.

Educational Offerings

SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors. 

Visit the SNMMI Learning Center.


Additional Resources

  • July 20, 2017Neuroendocrine Tumor Research Foundation Grant Opportunities

    NETRF is requesting applications for a new round of scientific and clinical research grants for advancing the treatment of and search for cures to neuroendocrine tumors (NETs). The grants, which will take effect in 2018, vary from $50,000 to $1.2 million and fall into three categories: accelerator grants, investigator grants, and pilot project grants. Some are available for as many as four years.
    (SNMMI News)

  • July 20, 2017SNMMI Technologist Section Announces 2017 Award Winners

    The Society of Nuclear Medicine and Molecular Imaging’s Technologist Section (SNMMI-TS) recognized contributions to and work in the field of nuclear medicine and molecular imaging during the SNMMI 2017 Annual Meeting in Denver, Colorado, held June 10-14. Several awards ceremonies were held to recognize the valuable role that SNMMI-TS members play in advancing the discipline of nuclear medicine technology.
    (Press Release)

  • July 19, 2017Brain scans may change care for some people with memory loss

    Findings, reported Wednesday, mark a first peek at a huge study under way to help determine if Medicare should start paying for specialized PET scans that find a hallmark of Alzheimer's — a sticky plaque called amyloid.For now, in addition to people who qualify for the IDEAS study, the Alzheimer's Association and Society of Nuclear Medicine and Molecular Imaging say unusually young dementia patients, younger than 65, also might be candidates for a PET scan. The scans shouldn't be used as a screening tool for people without symptoms or who worry they're at risk. Nor are they for people who can be diagnosed by standard means, or to determine disease severity.
    (SNMMI in the News)

  • July 17, 2017CMS Proposes 2018 Payment Rules for Outpatient Hospital Procedures and Physicians

    CMS's proposals and an initial assessment of them.
    (Government Relations News)

Spotlight

   

Now Available!
SNMMI 2017 Virtual Products

Access research presentations and popular sessions from the SNMMI 2017 Annual Meeting! Learn more.

Featured Resources